Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness. - Wikidata - wikimedia - TriplyDB

Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness.

Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness.

http://www.wikidata.org/entity/Q37124050

about

Clonality, virulence determinants, and profiles of resistance of clinical Acinetobacter baumannii isolates obtained from a Spanish hospital Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment Contribution of the Ade Resistance-Nodulation-Cell Division-Type Efflux Pumps to Fitness and Pathogenesis of Acinetobacter baumannii In Vitro Activity of the Novel Antimicrobial Peptide Dendrimer G3KL against Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.Colistin-Resistant Acinetobacter baumannii Clinical Strains with Deficient Biofilm Formation Protective Effect of a Synbiotic against Multidrug-Resistant Acinetobacter baumannii in a Murine Infection Model.Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii.Growth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.Genetic Regulation of Virulence and Antibiotic Resistance in Acinetobacter baumannii Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria.Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii.Polymyxin resistance caused by mgrB inactivation is not associated with significant biological cost in Klebsiella pneumoniae In Vivo Fitness Adaptations of Colistin-Resistant Acinetobacter baumannii Isolates to Oxidative Stress.Loss of LPS is involved in the virulence and resistance to colistin of colistin-resistant Acinetobacter nosocomialis mutants selected in vitro.In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment.Retention of virulence following adaptation to colistin in Acinetobacter baumannii reflects the mechanism of resistance.Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia.Editorial commentary: Polymyxin-resistant Acinetobacter baumannii: urgent action needed.Interplay between Colistin Resistance, Virulence and Fitness in Acinetobacter baumannii.Genomic insights into Colistin Resistant Klebsiella pneumoniae from a Tunisian teaching hospital.Phenotypic Changes Associated with Colistin Resistance due to Lipopolysaccharide Loss in Acinetobacter baumannii.Antibiotic Combinations That Enable One-Step, Targeted Mutagenesis of Chromosomal Genes

P2860

Q33610935-0BBFF154-5EAF-41EA-B3BF-506170E93F2C Q35551122-D2660201-BF41-49F1-BC20-5050FD69666F Q35662086-9CD2CE9E-1500-4819-A004-DA8AE9D393E3 Q36035894-3488D25C-B84C-42C9-84E9-B4E2F0F6C433 Q36290577-A5A77C96-59A2-459F-B825-89AB4A8A70E8 Q36644871-90745376-0959-4864-B4C4-E2BD6BF0B200 Q36888042-B5EACD7D-67A2-48D8-B143-1E9AB4A50D23 Q37544333-F9793190-CE3B-4B08-8E9D-A1F0B4C2B788 Q37544704-ED7CB8B1-670D-466A-9F35-FBBE8A2C10AC Q39038590-FB996F72-225E-4781-8EE2-1C7BF73CC6BB Q39063044-69DA0DE1-C75D-4B4D-8D3B-101BDD3EA74D Q39218893-6219A9D4-D545-42A7-8B5D-374F963EAE29 Q39503267-C077609D-AD7B-4F36-80D5-E3276FCB474E Q39565361-7FAAFFAD-FDB0-42E9-A41D-693FBF65B3D9 Q40403809-69BCA63B-F464-4C42-8D69-024F8761AE4C Q41031269-2AE494D3-1E39-4763-BD98-08CA0EBB51B5 Q41857059-7A70BF94-BB5B-4924-9625-63C7B5E436E7 Q41998459-40300E0E-A19F-44E0-9B3A-F9FC3D36EFFD Q42006976-55A94AA1-518A-420B-956C-85496984DC32 Q43226964-59518FDE-A671-4481-9CF7-D9B7B80BE35A Q47136007-3928757B-9F6F-4AEB-A42C-3030013181E9 Q47305294-99FD3EC9-97A3-4632-BE20-554F5A8556AF Q53696497-0D7D3CC8-6B53-4538-8744-4DEF9097252F Q58004246-0D28D8E4-84FF-476E-A0DB-A443F0CAAF9A

P2860

Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness.

http://www.wikidata.org/entity/Q37124050

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Colistin resistance in a clini ...... rulence and bacterial fitness.

@en

Colistin resistance in a clini ...... rulence and bacterial fitness.

@nl

type

label

Colistin resistance in a clini ...... rulence and bacterial fitness.

@en

Colistin resistance in a clini ...... rulence and bacterial fitness.

@nl

prefLabel

Colistin resistance in a clini ...... rulence and bacterial fitness.

@en

Colistin resistance in a clini ...... rulence and bacterial fitness.

@nl

P1433

Q37124050-94D2DE6E-6345-4409-8C22-ACF214924839

P1476

Q37124050-AF5B59C4-8B47-4489-B66E-1CD2606F0C7E

P2093

Q37124050-01231A6A-7723-44E1-9AB9-666C121809B9

Q37124050-39B8D2C6-0497-4F9B-B40C-E752B7288E3D

Q37124050-6B5FC6BD-C0E6-46DA-8550-07376CA25118

Q37124050-8B5C1B5E-8685-4806-849C-06BDD51EB634

Q37124050-E57F31E1-E2F4-45F3-816C-7EBA571A4754

P2860

Q37124050-0624CC52-54BF-47BD-A1D1-42318E25ACD7

Q37124050-141FEEFA-84E0-466E-8DFA-D6E7C6B83A17

Q37124050-1B01FE95-295C-4290-B527-73341E8A20EC

Q37124050-1D9CC1C0-2DD3-4DA0-AAEF-42883661F2A6

Q37124050-27BE3BCF-778F-475B-803A-C7DB6FF0C5A9

Q37124050-3B2727DD-CEC4-4357-AE7D-5A8DEA5D40F3

Q37124050-46EBE49E-652D-4BF3-8294-08EE608C1DD7

Q37124050-73E8BB05-6BE6-408D-B9B1-9203FB58A127

Q37124050-94E72C19-B0CA-41EF-9E81-F1FA47E8EC66

Q37124050-C0A2B9A2-FEF8-4FC8-AC8C-ACC469AC5468

P304

Q37124050-7DCD5BE5-9243-4310-855A-B48B2851E666

P31

Q37124050-B6BC72A9-D23B-4521-BA0C-1EC78DD302CE

P356

Q37124050-140594DC-64D6-4442-98C4-3DF57567144B

P407

Q37124050-6F5531C4-54CE-40B3-8CF8-7DE1CBDBC900

P433

Q37124050-BB1F64B0-7981-44A5-8D71-53085E555F12

P478

Q37124050-825570F8-BC2D-4B92-AB75-D3B1D242F66E

P50

Q37124050-E45C9DB1-C0FC-4631-8BFE-059032296AD7

P577

Q37124050-DC532968-F338-4396-9677-194A2DFC06C7

P698

Q37124050-E0F1047A-110F-4BD8-9570-C627C675A2D2

P921

Q37124050-4AE5F318-237E-4DC8-B329-93C17C2B10B9

P932

Q37124050-ED60C003-84D4-475E-8482-D35D9E6A99E5

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Colistin resistance in a clini ...... irulence and bacterial fitness

@en

P2093

Felipe Fernández-Cuenca

http://www.w3.org/2001/XMLSchema#string

Jerónimo Pachón

http://www.w3.org/2001/XMLSchema#string

Manuel Enrique Jiménez-Mejías

http://www.w3.org/2001/XMLSchema#string

Michael J McConnell

http://www.w3.org/2001/XMLSchema#string

Rafael López-Rojas

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.

Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.

Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii.

Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii.

The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A.

Real-time sequencing to decipher the molecular mechanism of resistance of a clinical pan-drug-resistant Acinetobacter baumannii isolate from Marseille, France.

Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system.

Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models.

Therapeutic options for Acinetobacter baumannii infections: an update.

The virulence variability of different Acinetobacter baumannii strains in experimental pneumonia.

P304

4587-4589

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00543-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

Juan Domínguez-Herrera

P577

2013-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23836165

http://www.w3.org/2001/XMLSchema#string

P921

Acinetobacter baumannii

P932

3754302

http://www.w3.org/2001/XMLSchema#string